Drugs / raceanisodamine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02279147 | Aug 2014 → Aug 2017 | autoinflammatory syndrome, obstructive jaundice | Wanqing Gu | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | raceanisodamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02279147 ↗ |
| Route | Intramuscular | “raceanisodamine（10mg）by intramuscular injection” NCT02279147 ↗ |